Pliant Therapeutics, Inc. (PLRX) stock
Close on Nov 12, 2026Market cap $45.82MP/E –Yield 0.00%
Pliant Therapeutics statistics
70 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Q3 FY2026, expected soon
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.36
- 2.29
Share statisticsIndustry
- Shares Change (YoY)
- 0.92%
- 10.9%
- Shares Change (QoQ)
- 0.11%
- 0.48%
- Float
- 54M
- 49M
- Shares Held by Insiders
- 13.0%
- 12.1%
- Shares Held by Institutions
- 77.7%
- 56.4%
Short sellingIndustry
- Short Interest
- 5M
- –
- Short Interest Change
- 5.32%
- -0.76%
- Short % of Float
- 9.06%
- 9.06%
- Short % of Shares Outstanding
- 7.88%
- 6.30%
- Days to Cover
- 16.20
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $1.81
- –
- 52-Week Low
- $0.73
- –
- 20-Day Moving Average
- $0.85
- –
- 50-Day Moving Average
- $0.98
- –
- 200-Day Moving Average
- $1.14
- –
- Average True Range (14)
- $0.04
- –
- Price Change (1 Week)
- -9.29%
- 1.51%
- Price Change (1 Month)
- -16.3%
- -2.37%
- Price Change (3 Months)
- -30.8%
- -21.1%
- Price Change (6 Months)
- -36.5%
- -22.8%
- Price Change (YTD)
- -39.3%
- -22.6%
- Price Change (1 Year)
- -55.7%
- -21.0%
- Price Change (3 Years)
- -94.2%
- -24.8%
- Price Change (5 Years)
- -95.6%
- -76.9%
- Average Volume (10 Days)
- 284,555
- –
- Average Volume (20 Days)
- 304,361
- –
- Average Volume (90 Days)
- 449,781
- –
- Relative Volume
- 1.17
- 0.80
- Relative Strength Index (14)
- 24.8
- 44.7
- Volatility (1 Year)
- 48.5%
- 80.2%
- Beta (5 Years)
- 1.01
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -55.3%
- -51.3%
- Return on Assets (ROA)
- -40.5%
- -40.7%
- Return on Capital Employed (ROCE)
- -62.5%
- -38.1%
Financial positionIndustry
- Current Ratio
- 8.05
- 3.31
- Quick Ratio
- 7.87
- 2.41
- Interest Coverage
- -698.18
- -6.35
EfficiencyIndustry
- Profits Per Employee
- -$1.84M
- -$683.67K
- Employee Count
- 49
- 75
- WACC
- 9.95%
- 10.0%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $141.08M
- $16.98M
- Net Cash Per Share
- $2.28
- $0.72
- Equity (Book Value)
- $126.63M
- $52.68M
- Book Value Per Share
- $2.05
- $1.50
- Tangible Book Value
- $126.63M
- $26.74M
- Working Capital
- $126.29M
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- $0
- -$944.00K
- FCF Per Share
- -$1.08
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -197.2%
- -21.0%
- FCF Yield
- -145.8%
- -9.44%
- Dividend Yield
- 0.00%
- 1.88%
- Shareholder Yield
- 0.00%
- 0.00%
- Dividend Per Share
- $0.00
- $0.83
- Years of Dividend Growth
- 0
- 0
Taxes and interestIndustry
- Interest Expense
- $136.00K
- $2.97M
- Income Tax
- $0
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- -7.95
- 0.26
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | PLRX | S&P 500 | Difference | PLRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -24.9% | -2.7% | −22.3 pts | ||
| 3 months | -30.8% | -1.7% | −29.1 pts | ||
| Year to date | -39.3% | +11.9% | −51.2 pts | ||
| 1 year | -58.9% | +12.0% | −70.9 pts | ||
| 3 years | -94.6% | +78.2% | −172.8 pts | -62.3% | +21.2% |
| 5 years | -95.6% | +73.2% | −168.8 pts | -46.4% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
5M PLRX shares were sold short on Oct 30, 2026, up 5.3% from the previous report, or 9.06% of the shares available to trade. At recent volumes it would take 16.2 days to buy them back. Over the last 20 sessions, 37.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,881,070 | +5.3% | 301,369 | 16.2 |
| Oct 15, 2026 | 4,634,593 | +9.1% | 447,369 | 10.4 |
| Sep 30, 2026 | 4,246,484 | +15.0% | 372,372 | 11.4 |
| Sep 15, 2026 | 3,692,416 | +12.6% | 416,117 | 8.9 |
| Aug 31, 2026 | 3,278,573 | +18.4% | 456,271 | 7.2 |
| Aug 14, 2026 | 2,768,737 | -1.3% | 361,784 | 7.7 |
| Jul 31, 2026 | 2,806,615 | -0.5% | 490,096 | 5.7 |
| Jul 15, 2026 | 2,821,841 | +9.3% | 862,175 | 3.3 |
| Jun 30, 2026 | 2,582,648 | -8.3% | 367,554 | 7.0 |
| Jun 15, 2026 | 2,816,654 | -18.0% | 537,720 | 5.2 |
| May 29, 2026 | 3,436,210 | -0.2% | 568,852 | 6.0 |
| May 15, 2026 | 3,444,679 | +0.4% | 329,821 | 10.4 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?